- +1 858 909 0079
- +1 858 909 0057
- [email protected]
- +1 858 909 0079
- [email protected]
Cat# | Product Name | Swiss Prot# | Size | Price (US$) | Order |
PN0309 | Recombinant Protein-Duck adenovirus 1 Core protein 1 (a.a.16 to 160) | A1E169 | 100 µg | 1195 | |
PN0310 | Recombinant Protein-Duck adenovirus 1 PVIII protein (a.a.21 to 250) | A2TF04 | 100 µg | 1195 | |
PN0311 | Recombinant Protein-Duck adenovirus 1 52K protein (a.a.21 to 338) | O11416 | 100 µg | 1195 | |
PN0312 | Recombinant Protein-Duck adenovirus 1 PVI protein (a.a.21 to 230) | O11420 | 100 µg | 1195 | |
PN0313 | Recombinant Protein-Duck adenovirus 1 E4 protein (a.a.34 to 295) | O11425 | 100 µg | 1195 | |
PN0314 | Recombinant Protein-Duck adenovirus 1 24K (a.a.21 to 285) | P87657 | 100 µg | 1195 | |
RPN0309 | cDNA-Duck adenovirus 1 Core protein 1 (a.a.16 to 160) | A1E169 | 2 µg | 720 | |
RPN0310 | cDNA-Duck adenovirus 1 PVIII protein (a.a.21 to 250) | A2TF04 | 2 µg | 1145 | |
RPN0311 | cDNA-Duck adenovirus 1 52K protein (a.a.21 to 338) | O11416 | 2 µg | 1585 | |
RPN0312 | cDNA-Duck adenovirus 1 PVI protein (a.a.21 to 230) | O11420 | 2 µg | 1045 | |
RPN0313 | cDNA-Duck adenovirus 1 E4 protein (a.a.34 to 295) | O11425 | 2 µg | 1305 | |
RPN0314 | cDNA-Duck adenovirus 1 24K (a.a.21 to 285) | P87657 | 2 µg | 1320 |
Duck adenovirus 1 cDNA and recombinant antigen
Duck adenovirus 1 (DAV-1) is a virus in the family Adenoviridae that affects ducks and geese. It is a common cause of viral respiratory disease in these birds, particularly in commercial duck-farming operations. The virus is spread through contact with contaminated respiratory secretions, such as saliva or nasal discharge, or by ingesting contaminated feed or water. Symptoms of DAV-1 infection in ducks and geese can include respiratory signs, such as coughing, sneezing, and nasal discharge, as well as weight loss, decreased egg production, and reduced growth in young birds. In severe cases, the virus can cause high levels of mortality, especially in young birds. There is no specific treatment for DAV-1 infection, but supportive care, such as keeping affected birds in a clean and dry environment, can help manage symptoms. Prevention measures include practicing good biosecurity, such as limiting the movement of birds and equipment between farms, and properly cleaning and disinfecting contaminated equipment.
Duck Adenovirus (DAdV) is a pathogenic virus that affects domestic and wild ducks, causing various clinical signs such as respiratory distress, nervous system disorders, and hepatic dysfunction. The virus belongs to the family Adenoviridae and has a non-enveloped icosahedral capsid that encloses a double-stranded DNA genome. The viral genome encodes for several proteins, including Core protein 1, PVIII protein, 52K protein, PVI protein, E4 protein, and 24K protein, which are essential for the viral replication and assembly.
The duck adenovirus 1 (DAV-1) antigen refers to a specific molecule or substance in the virus that triggers an immune response. Antigens are recognized by the immune system and can be used to diagnose an infection by detecting antibodies produced in response to the virus. In the case of DAV-1, antigens may include viral proteins or other components of the virus. Detection of DAV-1 antigens can be used to diagnose an active infection, especially in birds that have not yet developed a significant immune response. Antigen tests for DAV-1 are generally faster and less expensive than other forms of testing, such as PCR, but may not be as sensitive.
The genome of duck adenovirus encodes several viral proteins, including:
Core protein 1: This is a major component of the viral core, forming the shell that encloses the viral DNA genome.
PVIII: This is a minor core protein that is involved in stabilizing the viral capsid and protecting the viral genome.
52K: This is a viral protein that is involved in viral DNA replication and is required for efficient virus growth.
PVI: This is a minor core protein that is involved in capsid assembly and stabilization.
E4,24K: This is a non-structural protein that is involved in viral replication and the modulation of host cell processes to facilitate viral replication and pathogenesis.
Understanding the functions and interactions of these proteins is crucial for the development of effective therapies and vaccines against DAdV. Several strategies have been proposed for the prevention and control of the disease, including the development of recombinant vaccines, antiviral drugs, and improved biosecurity measures. Continued research into the structure and function of these proteins will be essential for the development of effective control measures against DAdV and other related adenoviruses.
The use of recombinant proteins/cDNA in academic research and therapeutic applications has skyrocketed. However, in heterologous expression systems, successful recombinant protein expression is dependent on a variety of factors, including codon preference, RNA secondary structure, and GC content. When compared to pre-optimization, more and more experimental results demonstrated that the expression level was dramatically increased, ranging from two to hundred times depending on the gene. Bioclone has created a proprietary technology platform that has resulted in the creation of over 6,000 artificially synthesized codon-optimized cDNA clones (cloned in E. coli expression Vector), which are ready for production of the recombinant proteins.
Get the Latest News and Updates by Email
6393 Nancy Ridge Dr. Suite A
San Diego, CA 92121 USA
Fax: +1-858-909-0057
Get the Latest News and Updates by Email
© 2023 Bioclone Inc. All Rights Reserved.
Magnetic Beads Make Things Simple